Immunomodulatory molecules in colorectal cancer liver metastasis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Colorectal cancer liver metastasis (CRLM) involves immunosuppressive proteins in the tumor microenvironment (TME). Understanding these molecules is key to developing new treatments for this advanced cancer.
Area Of Science
- Oncology
- Immunology
- Molecular Biology
Background
- Colorectal cancer (CRC) is a leading cause of cancer death, with liver metastasis (CRLM) occurring in ~50% of patients, signifying a poor prognosis.
- The liver's immune tolerance creates an immunosuppressive tumor microenvironment (TME) that aids cancer progression.
- Mechanisms of immune evasion in CRLM are not fully understood, particularly the roles of membrane and secreted proteins.
Purpose Of The Study
- To review recently identified membrane and secreted proteins involved in immune evasion within the TME of colorectal cancer.
- To elucidate the specific mechanisms by which these proteins promote colorectal cancer liver metastasis.
- To discuss strategies for identifying proteins critical to CRLM immune evasion and potential therapeutic targets.
Main Methods
- Literature review of recent studies on colorectal cancer liver metastasis.
- Analysis of identified membrane and secreted proteins acting as immunomodulatory molecules.
- Examination of mechanisms contributing to immune evasion in the tumor microenvironment.
Main Results
- Numerous membrane and secreted proteins have been identified with both immunostimulatory and immunosuppressive roles in the TME.
- These proteins significantly influence immune evasion in both primary CRC and metastatic lesions, particularly in CRLM.
- Specific protein functions in promoting CRLM immune evasion have been highlighted.
Conclusions
- Understanding the role of specific proteins in CRLM immune evasion is crucial for improving patient outcomes.
- Screening strategies can identify key proteins involved in CRLM immune evasion.
- These proteins represent potential therapeutic targets for novel CRLM treatments.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...